Tim Watkins, CMO & Head of Development: Contineum Therapeutics CTNM Sell · Filed 03/02

Trade details

Type: Insider sale
Amount: $54,237.22
Shares · price: 3,611 sh · $15.02 a share
Held after: 0 sh
Stock: Contineum Therapeutics CTNM
Person: Tim WatkinsCMO & Head of Development
Trade date: 26/03/02
Filed: 26/03/02
Days to filing: 0 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Tim Watkins's recent trades

Tim WatkinsCMO & Head of Development
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$162.5K
10,833 sh
$162.5K
Filed 06/30
Traded 06/30
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$39.5K
2,800 sh
$39.5K
Filed 01/30
Traded 01/28
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$11.7K
811 sh
$11.7K
Filed 01/30
Traded 01/28
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$43.5K
3,611 sh
$43.5K
Filed 25/12/30
Traded 25/12/29
Tim WatkinsCMO & Head of Development
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$134.4K
10,833 sh
$134.4K
Filed 25/12/29
Traded 25/12/29

Tim Watkins, CMO — sold $54.2K of Contineum Therapeutics CTNM · 100.0% of holdings · 10b5-1 plan | Whalegun